Frank D. Lee Pacira Bio Sciences, Inc. (PCRX) insider trading activity

Frank D. Lee is Chief Executive Officer of Pacira BioSciences, Inc.. Currently has a direct ownership of 440,500 shares of PCRX, which is worth approximately $10.5 Million. The most recent transaction as insider was on Jan 02, 2026, when has been sold 9,272 shares (Common Stock) at a price of $24.46 per share, resulting in proceeds of $226,793. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 441K

1.76% 3M change

347.62% 12M change

Total Value Held $10.5 Million

Frank D. Lee Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2026	SELL Payment of exercise price or tax liability	$226,793 $24.46 p/Share	9,272 Reduced 2.06%	440,500 Common Stock
Feb 01 2025	BUY Grant, award, or other acquisition	-	350,000 Added 43.84%	448,409 Common Stock
Jan 02 2025	SELL Payment of exercise price or tax liability	$171,843 $18.33 p/Share	9,375 Reduced 8.7%	98,409 Common Stock
Aug 12 2024	BUY Open market or private purchase	$99,994 $12.1 p/Share	8,264 Added 7.12%	107,784 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	99,520 Added 50.0%	99,520 Common Stock

Also insider at

FMTX

Forma Therapeutics Holdings, Inc. Healthcare

President and CEO

BOLT

Bolt Biotherapeutics, Inc. Healthcare

BHC

Bausch Health Companies Inc. Healthcare

Director

FDL

Frank D. Lee

Chief Executive Officer

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCRX shares.

Notify only if

Value

Insider Trading

Get notified when an Pacira Bio Sciences, Inc. insider buys or sells PCRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Pacira BioSciences, Inc.

Track Activities on PCRX

Account